Handelsbanken Fonder
CSII

Handelsbanken Fonder’s Cardiovascular Systems, Inc. CSII Stock Holding History

Handelsbanken Fonder’s Portfolio CSII Stock Details CSII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-11,700
Closed -$168K – 1608
2022
Q2 		$168K Hold
11,700
– – ﹤0.01% 1522
2022
Q1 		$264K Hold
11,700
– – ﹤0.01% 1566
2021
Q4 		$220K Hold
11,700
– – ﹤0.01% 1686
2021
Q3 		$384K Buy
11,700
+1,000
+9% +$37.3K ﹤0.01% 1496
2021
Q2 		$456K Buy
10,700
+3,000
+39% +$117K ﹤0.01% 1442
2021
Q1 		$295K Hold
7,700
– – ﹤0.01% 1456
2020
Q4 		$337K Hold
7,700
– – ﹤0.01% 1355
2020
Q3 		$303K Hold
7,700
– – ﹤0.01% 1233
2020
Q2 		$243K Buy
+7,700
New +$288K ﹤0.01% 1309

Other funds holding CSII

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Handelsbanken Fonder's CSII Position: Q3 2022 in Review

Handelsbanken Fonder sold out of Cardiovascular Systems, Inc. (CSII) in Q3 2022, closing a stake of 11,700 shares — an estimated $168K sold.

Handelsbanken Fonder first reported a position in CSII in Q2 2020 and held it in 9 quarters. The position peaked at $456K in Q2 2021. 163 funds tracked by Wall St. Rank hold CSII as of Q3 2022.

  • Handelsbanken Fonder reported no remaining Cardiovascular Systems, Inc. position as of Q3 2022 after selling out during the quarter.
  • Handelsbanken Fonder sold 11,700 Cardiovascular Systems, Inc. shares in Q3 2022, an estimated $168K.
  • Handelsbanken Fonder first reported a position in Cardiovascular Systems, Inc. in Q2 2020 and held it in 9 quarters.
  • Handelsbanken Fonder's Cardiovascular Systems, Inc. position peaked at $456K in Q2 2021.
  • 163 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q3 2022.

Based on Handelsbanken Fonder's 13F filing for Q3 2022, filed 27 Oct 2022.